Compounds > psilocybin
Page last updated: 2024-08-21

psilocybin and Disease Models, Animal

psilocybin has been researched along with Disease Models, Animal in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's5 (83.33)2.80

Authors

AuthorsStudies
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1
Chen, J; Chen, T; Cheng, L; Liu, H; Liu, Z; Ma, J; Pi, C; Shen, H; Tang, J; Wei, Y; Xiong, L; Yuan, J; Zhang, X; Zhao, L; Zhong, Y; Zuo, Y1
Germann, CB1
Güngör, C; Meinhardt, MW; Mertens, LJ; Skorodumov, I; Spanagel, R1
Andreasen, JT; Kristensen, JL; Odland, AU1
Christiansen, SL; Elfving, B; Højgaard, K; Jefsen, O; Müller, HK; Nutt, DJ; Wegener, G1

Reviews

1 review(s) available for psilocybin and Disease Models, Animal

ArticleYear
Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants.
    Pharmacological research, 2023, Volume: 194

    Topics: Animals; Antidepressive Agents; Depressive Disorder, Major; Disease Models, Animal; Ketamine; Mice; Psilocybin; Receptors, N-Methyl-D-Aspartate

2023

Other Studies

5 other study(ies) available for psilocybin and Disease Models, Animal

ArticleYear
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020
The Psilocybin-Telomere Hypothesis: An empirically falsifiable prediction concerning the beneficial neuropsychopharmacological effects of psilocybin on genetic aging.
    Medical hypotheses, 2020, Volume: 134

    Topics: Aging; Aging, Premature; Animals; Anxiety; Brain-Derived Neurotrophic Factor; Consciousness; Depression; Disease Models, Animal; DNA Methylation; Endocrine System; Humans; Models, Genetic; Models, Psychological; Neurotransmitter Agents; Oxidative Stress; Personality; Psilocybin; Psychotropic Drugs; Research Design; Serotonin Plasma Membrane Transport Proteins; Stress, Psychological; Telomere Shortening

2020
Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2020, Volume: 45, Issue:8

    Topics: Animals; Disease Models, Animal; Female; Hallucinogens; Lysergic Acid Diethylamide; Male; Psilocybin; Rats; Recurrence

2020
Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice.
    Behavioural brain research, 2021, 03-05, Volume: 401

    Topics: Aminopyridines; Amphetamines; Animals; Behavior, Animal; Citalopram; Compulsive Behavior; Disease Models, Animal; Female; Fluorobenzenes; Indoles; Mice; Piperidines; Psilocybin; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin Antagonists

2021
Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat.
    Acta neuropsychiatrica, 2019, Volume: 31, Issue:4

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Male; Motor Activity; Psilocybin; Rats

2019